[October 11-13, 2015]
The World Health Summit is the annual conference of the M8 Alliance of Academic Health Centers, Universities and National Academies. Through the Inter Academy Medical Panel (IAMP), it is organized in collaboration with national academies of science in more than 67 countries.
DNDi participated in a workshop on global health research and development.
Global Health: Research and Development
Date: 11 October, 2015
Dr Kei Katsuno, Director, Investment Strategy & Development, Global Health Innovative Technology Fund (GHIT), Japan
Jean-Pierre Paccaud, Director, Business Development, Drugs for Neglected Diseases initiative (DNDi), Switzerland
Dr Ann Aerts, Director, Novartis Foundation, Switzerland
The relationship between R&D and effective healthcare delivery in low-Income settings
Dr Robert Arch, Director, Value Creation Alternatives, Takeda Pharmaceutical Company Ltd., USA
NTDs as a sustainable business investment: cross-sector global health R&D collaboration in the 21st century
Dr David Reddy, CEO, Medicines for Malaria Venture (MMV), Switzerland
Relevance of global health R&D in the age of SDGs
|Prof Dr. Lorenzo Savioli, Chair of the Executive Group, Global Schistosomiasis Alliance (GSA), Switzerland
Importance of cross-sector partnerships and high-level policy buy-in
More information: World Health Summit website